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Abstract
Introduction: Ulcers are frequent lesions of the oral mucosa. Generally, they are circumscribed
round or elliptical lesions surrounded by an erythematous halo and covered with an inflammatory
exudate in their central portion, and are accompanied by painful symptoms. Oral ulcers affect 20%
of the population, especially adolescents and young adults. The etiopathogenesis includes
immunological alterations, infections, nutritional deficiency, trauma, food and contact allergies,
autoimmune diseases, neoplasms, and psychosomatic, genetic and environmental factors.
Case presentation: A 78-year-old Caucasian woman was referred by her dentist to our
outpatient clinic with a 4-week history of an oral ulceration after using an antidepressant (sertraline
hydrochloride). On the basis of the clinical findings and anamnesis, the occurrence of the lesion was
attributed to the use of the drug. Exfoliative cytology was performed, to reassure the patient that
it was not oral cancer, which revealed the presence of a nonspecific inflammatory reaction. The
drug was replaced and resolution of symptoms was observed.
Conclusion: Exfoliative cytology should be the complementary examination of choice in cases of
oral ulcers with a suspicion of drug interaction. Although this is a rare event in dental practice,
dentists should be aware of the diagnostic possibility of drug-induced ulcers and should cooperate
with the clinician to adjust the prescribed medication to resolve the symptoms.
Introduction
Oral ulcers are inflammatory lesions of the oral mucosa
that affect approximately 20% of the population [1].
These ulcers are accompanied by painful symptoms and
are generally characterized by shallow oval circumscribed
lesions surrounded by an erythematous halo and covered
with a fibrinous exudate in their central portion. Oral
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ulcers manifest as acute (duration of up to 6 weeks),
chronic, or recurrent solitary or multiple lesions [2].
Numerous causes and factors involved in the formation of
these lesions have been reported in the literature, includ-
ing immunological alterations, infections, nutritional
deficiency, repetitive trauma to the mucosa, food and con-
tact allergies, autoimmune diseases and neoplasms, as
well as psychosomatic, genetic and environmental factors
[3].
Sertraline hydrochloride is an antidepressant agent used
in clinical practice, which acts on the serotonin neuro-
transmitter. Antidepressants such as selective and potent
serotonin reuptake inhibitors potentiate serotonergic
neurotransmission and show a low frequency of adverse
reactions [4].
A variety of cases of ulcerated lesions have been reported
in the oral mucosa associated with the use of different sys-
temic medications. This is of great interest to dentists who
are frequently responsible for the diagnosis of these
lesions. We report the case of a patient who developed
oral ulceration after the use of an antidepressant (sertra-
line hydrochloride).
Case presentation
A 78-year-old Caucasian woman was referred by her den-
tist to our outpatient clinic, with a 4-week history of an
oral ulceration. She mentioned that she had basocellular
carcinoma in her face and stomach cancer. Extra-oral clin-
ical examination showed facial symmetry and palpable,
mobile, smooth and asymptomatic submandibular
lymph nodes. A shallow ulcer with an erythematous bor-
der, measuring about 1.5 cm at its maximum diameter,
was noted upon intraoral examination. The ulcer was
located in the mucosa of the lingual region of the left
lower premolars (Figure 1) and was accompanied by pain-
ful symptoms.
Upon anamnesis, the patient reported the use of sertraline
hydrochloride for the treatment of depression at an initial
dose of 50 mg, which was subsequently increased to 100
mg when the occurrence of the lesion was first noted. After
evaluation of the medication by the physician responsi-
ble, sertraline was replaced by 75 mg of venlafaxine and
exfoliative cytology of the ulcer was performed.
Exfoliative cytology of the lesion showed superficial and
intermediate pavement epithelial cells presenting diverse
inflammatory and degenerative alterations, such as vacu-
olization, a perinuclear halo, an enlarged nucleus, binu-
cleation and lysis, numerous mono- and
polymorphonuclear leukocytes, thick and filamentous
mucus, and cell remnants, in addition to a mixed flora
consisting of bacteria and Candida hyphae (Figure 2).
Mouth rinsing with a betamethasone elixir three times per
day for 3 minutes was initially prescribed for a period of 5
days. On her return visit, the patient presented with
improvement of the clinical symptoms and was instructed
to continue mouth rinsing for an additional 7 days. Two
weeks later, she returned, complaining of persistent pain
in the affected area. The patient returned after 21 days
showing significant improvement of the clinical symp-
toms and re-epithelization of the ulcer. The patient was
followed up for 4 months at weekly intervals and was dis-
charged after this period. She presented with no further
oral complaints over 2 years of follow-up.
Discussion
Our patient presented with an oral ulcer and was referred
by her dentist, who was worried about the possibility of
oral cancer. Oral ulcers can be the first manifestation of
systemic diseases of immunogenetic origin, such as
Behçet's disease [5] and others. Diseases such as pemphi-
gus and pemphigoid may also impair differential diagno-
sis with nonspecific secondary ulcers after rupture of the
bullae [6]. In such cases, a biopsy combined with immun-
ofluorescence is a fundamental tool for a definitive diag-
nosis.
Deficiencies in iron, folic acid, B12 complex and B6 vita-
mins, and trace elements such as zinc have been variably
related to the occurrence of ulcers [7].
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Several studies have evaluated the use of drugs that may
induce the formation of ulcers, including medications
such as niflumic acid, captopril, piroxicam and phenobar-
bital. Cytotoxic agents used in antineoplastic therapies
affect dividing cells, a phenomenon that manifests in the
oral mucosa, inducing ulcers in some patients [8]. Alendr-
onate, a drug prescribed for the treatment of patients with
osteoporosis, has also been associated with the occurrence
of oral ulcers. In a review of 200 patients investigating the
adverse effects of drugs in the oral cavity, Smith and Burt-
ner observed dry mouth in 80.5%, dysgeusia in 47.5%
and stomatitis in 33.9% [9]. In another review on the
adverse effects of drugs, Scully and Bagan reported adverse
manifestations such as hypersalivation, white lesions,
burning mouth sensation, mucositis, neoplasms, pemphi-
gus, pemphigoid and other bullous disorders, mucosal
pigmentation, lichenoid reactions, cheilitis, neuropathies,
and halitosis [10]. The authors reported that aphthous
ulcerations were observed after the use of β-blockers such
as labetalol, captopril, nicorandil and nonsteroidal anti-
inflammatory drugs and also after the use of mycopheno-
late or sirolimus, sodium lauryl sulfate, protease inhibi-
tors, and sulfonamides.
In the era of transplantation, a frequent medical concern
is the development of ulcers that might be exacerbated by
the administration of immunosuppressive medications
such as mycophenolate mofetil, which has been used in
combination with calcineurin inhibitors and steroids. The
drug-induced ulcerated lesions disappear when the medi-
cation is discontinued [11].
One study has shown the development of oral ulcers in
four patients with angina pectoris who used nicorandil, a
nicotinamide ester. In the cases studied, the lesions
improved after dose reduction or interruption of the med-
ication [12].
Stress has been identified as an important factor triggering
the occurrence of oral ulcers, with the use of antidepres-
sants being recommended in some patients for the con-
trol of recurrent aphthous ulcers [13]. However, in this
study, after the clinical diagnosis of depression and pre-
scription of sertraline hydrochloride, the patient devel-
oped an adverse reaction to the drug characterized by the
occurrence of an ulcer in the oral mucosa. Replacement of
the medication was requested, which led to the improve-
ment of symptoms.
Smears showing superficial and intermediate epithelial cells with inflammatory and degenerative alterations such as a perinu- clear halo, cytoplasmic lysis and vacuolization, and numerous leukocytes, sometimes aggregated with filamentous mucus  (Papanicolaou stain, 630×) Figure 2
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As the patient had a previous history of stomach cancer,
she was upset about the possibility of the ulcer being an
oral cancer lesion. Exfoliative cytology was performed to
lessen the patient's worries about the lesion. Exfoliative
cytology is a viable alternative and should be the comple-
mentary examination of choice in these situations.
Because an early diagnosis of oral cancer is essential for
survival and to minimize public health expenses, exfolia-
tive cytology might be used as a complementary examina-
tion in the monitoring of cancer risk factors [14].
Oral cancer mainly affects the floor of the mouth, the lat-
eral border of the tongue and the soft palate, although
other areas of the mouth may also be involved. Many
cases of oral cancer are diagnosed during the advanced
phase, a fact that results in an unfavorable prognosis and
high mortality, in addition to high costs of treatment and
an increased number of complications. Thus, an early
diagnosis and preventive approach are of extreme impor-
tance in this disease [15].
The clinical manifestations of adverse reactions to drugs
depend on the dose and type of medication, as well as on
individual differences related to the patient. These reac-
tions might be rapid or persist for a number of days after
the use of the drug. According to the literature and to clin-
ical practice, in most drug-induced reactions improve-
ment of clinical symptoms occurs after dose reduction or
interruption of the medication. Generally, these adverse
reactions occur in the first or second week after the begin-
ning of the therapy of choice and depend on the dose and
cumulative toxicity of the drug, with the reactions usually
ranging from moderate to severe. However, severe reac-
tions require rapid withdrawal of the drug or its replace-
ment. Many patients use multiple systemic medications
that may eventually be supplemented with other drugs
necessary for dental treatment [10].
Oral ulcers are frequent in oral diagnosis clinics and the
lesions must be carefully examined, including the aspect
of the surface, the presence of an erythematous halo and
the deepness of the lesion. The etiological diagnosis is
based on the presence of associated signs and symptoms
that should be investigated during anamnesis.
The dentist should have pharmacological knowledge of
the prescribed drug and of its possible interaction with
other medications. Thus, cooperation between the treat-
ing doctor and the dentist is necessary in order to choose
the best treatment that will guarantee the well-being and
best quality of life of the patient.
Conclusion
Exfoliative cytology should be the complementary exami-
nation of choice in cases of oral ulcers with a suspicion of
drug interaction. Although this is a rare event in dental
practice, the dentist should be aware of the diagnostic pos-
sibility of drug-induced ulcers and should cooperate with
the clinician to adjust the prescribed medication for
symptom resolution.
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